US executive order aims to reduce prescription drug costs by matching prices with other developed countries, facing legal ...

Adoption of lecanemab, a novel infusion treatment for Alzheimer's disease (AD), has been disproportionately higher among patients who are male, white, from urban areas, and have higher socioeconomic ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

While much of Washington, DC’s attention this week has been focused on congressional action around budget reconciliation, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

RFK Jr., Trump, and Republicans want AI to fill the gaps as they move to throw millions off Medicaid, gut funding for ...

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

After significant fanfare and anticipation, President Trump issued his “Delivering Most-Favored Nation Prescription Drug Pricing to American ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...